|
Real-time Estimate
Cboe BZX
10:38:02 31/08/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 2.005 USD | +7.22% |
|
+8.33% | -72.62% |
| 29/08 | Karyopharm Therapeutics Inc. - Special Call | |
| 13/08 | Karyopharm Therapeutics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| Market Cap | 4.24Cr 3.65Cr 3.43Cr 3.13Cr 5.88Cr 403.57Cr 5.92Cr 41Cr 16Cr 204.64Cr 16Cr 16Cr 677.6Cr | P/E 2026 * |
-0.4x | P/E 2027 * | -0.78x |
|---|---|---|---|---|---|
| Enterprise Value | 4.24Cr 3.65Cr 3.43Cr 3.13Cr 5.88Cr 403.57Cr 5.92Cr 41Cr 16Cr 204.64Cr 16Cr 16Cr 677.6Cr | EV / Sales 2026 * |
0.31x | EV / Sales 2027 * | 0.24x |
| Free-Float |
95.33% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript : Karyopharm Therapeutics Inc.
| 1 day | +7.49% | ||
| 1 week | +8.33% | ||
| Current month | +4.95% | ||
| 1 month | +4.95% | ||
| 3 months | -79.48% | ||
| 6 months | -77.93% | ||
| Current year | -72.62% |
| 1 week | 1.79 |  | 2.06 |
| 1 month | 1.79 | | 2.18 |
| Current year | 1.79 | | 10.99 |
| 1 year | 1.79 | | 10.99 |
| 3 years | 1.79 | | 29.25 |
| 5 years | 1.79 | | 220.95 |
| 10 years | 1.79 | | 444.15 |
| Manager | Title | Age | Since |
|---|---|---|---|
Richard Paulson
CEO | Chief Executive Officer | 58 | 03/05/2021 |
Lori Macomber
DFI | Director of Finance/CFO | 55 | 03/01/2025 |
Amama Sadiq
CTO | Chief Tech/Sci/R&D Officer | - | 01/04/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Barry Greene
BRD | Director/Board Member | 62 | 01/01/2013 |
| Director/Board Member | 61 | 01/04/2013 | |
Garen Bohlin
BRD | Director/Board Member | 78 | 03/10/2013 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 28/07/26 | Sell | Executive/Senior Manager | -189 | 0.0008% | ||
| 21/05/26 | Free | Director | 15,508 | 0.0688% | ||
| 21/05/26 | Free | Director | 15,508 | 0.0688% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +7.22% | +8.33% | -70.28% | -89.51% | 4.24Cr | |
| +0.41% | -3.71% | +38.05% | -3.47% | 7.93TCr | |
| -0.44% | +1.94% | -19.41% | -36.90% | 5.92TCr | |
| +3.91% | +2.70% | +489.69% | +26.16% | 5.51TCr | |
| +2.15% | -2.13% | -1.37% | +30.77% | 4.99TCr | |
| -0.55% | -2.14% | +8.08% | +160.02% | 4.79TCr | |
| +0.12% | +0.14% | +56.42% | -18.31% | 3.23TCr | |
| -0.77% | -3.31% | +43.93% | +91.77% | 2.52TCr | |
| -3.44% | +1.37% | +7.18% | +188.73% | 2.39TCr | |
| -3.52% | -0.49% | +58.94% | +112.57% | 1.69TCr | |
| Average | +0.54% | -1.41% | +61.12% | +46.18% | 3.9TCr | |
| Weighted average by Cap. | +0.39% | -1.88% | +85.35% | +41.85% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 14Cr 12Cr 11Cr 10Cr 19Cr 1.29TCr 19Cr 129.93Cr 51Cr 654.38Cr 51Cr 50Cr 2.17TCr | 17Cr 15Cr 14Cr 13Cr 24Cr 1.65TCr 24Cr 166.28Cr 65Cr 837.45Cr 65Cr 64Cr 2.77TCr |
| Net income | -16Cr -14Cr -13Cr -12Cr -22Cr -1.52TCr -22Cr -153.44Cr -60Cr -772.79Cr -60Cr -59Cr -2.56TCr | -11Cr -9.89Cr -9.29Cr -8.48Cr -16Cr -1.09TCr -16Cr -110.07Cr -43Cr -554.36Cr -43Cr -42Cr -1.84TCr |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 31/26/31 | $2.010 | +7.49% | 7,58,128 |
| 28/26/28 | $1.870 | -3.61% | 8,27,353 |
| 27/26/27 | $1.940 | -1.02% | 11,08,229 |
| 26/26/26 | $1.960 | +2.08% | 7,53,814 |
| 25/26/25 | $1.920 | +3.23% | 10,60,619 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- KPTI Stock
Select your edition
All financial news and data tailored to specific country editions
